Get notified when LION files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Risk Profile Improvements

  • 5.500% Notes Noteholder Litigation (removed) — Litigation over the May 2024 indenture amendment settled and dismissed with prejudice on July 9, 2026, removing the risk of voiding the exchange transaction.
NYSE: LION Lionsgate Studios Corp. 10-Q

Revenue surged 47.7% to $776.6M on Michael theatrical release; operating income swung positive

Filed August 6, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 11, 2025 · ~2 min read

Key Changes

  • high

    Operating income swung positive to $25.6M from a -$10.6M loss YoY, driven by Motion Picture revenue surging 120% to $587.3M on the theatrical release of Michael.

    MD&A: Operating Results verify on EDGAR →
  • high

    Remaining performance obligations increased to $1.9B from $1.6B YoY, with backlog rising to $1.5B from $1.2B, indicating stronger forward revenue visibility across Motion Picture and Television Production.

    MD&A: Remaining Performance Obligations verify on EDGAR →
  • high

    Operating cash flow swung positive to $54.1M provided from -$109.1M used YoY, a $163.2M improvement, while cash and cash equivalents increased to $425.8M from $186.1M.

    MD&A: Cash Flows verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (GTM 10-Q) is open in full — no account needed.

Partner

Trade LION commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 7, 2026 · How we verify